Murashko: You cannot recommend anti-malear drugs for the prevention of covid-19

The head of the Ministry of Health, Mikhail Murashki, said that it is impossible to recommend antimalarial drugs for the prevention of Covid-19, because "there are adverse outcomes due to their use."

Earlier, he stated that anti-male drugs are quite effective in the treatment of COVID-19. “These are antimalarial drugs. They showed quite good effectiveness, but are not rescuing in all situations, do not save life, ”he said .

In mid -April, the government instructed the National Medical Research Center for Cardiology to transfer free to medical organizations that treat patients with coronavirus, the drug "Gidroxichlorokhin".

Gidoxichlorokhin is an anti -malarial drug unregistered in Russia, its effectiveness in the treatment of coronavirus infection is currently not confirmed.

At the disposal it is said that 68 thousand packages of hydroxykhlorokhin at a free basis were provided by the Chinese company Shanghai Farmasyutikals Holding Co..

Earlier it was reported that the employees of the Federal Biological Agency created a treatment regimen for a new coronavirus infection Covid-19, which is based on the antimalarial drug Meplokhin. The development was proposed to include in the methodological recommendations of the Ministry of Health on the prevention, diagnosis and treatment of coronavirus infection.